To conclude, our present results suggest that by hampering the interaction between CXCL12 and CXCR4, the LIT-927 neutraligand limits the signaling occurring into T and B cells in lupus context with potential favorable outcome on the course of the lupus disease that needs further investigations. The gene discussed is CXCL12; the disease is systemic lupus erythematosus.